ReviewPrenatal management of the fetus with isolated congenital diaphragmatic hernia in the era of the TOTAL trial
Introduction
The prevalence of congenital diaphragmatic hernia (CDH) ranges between one and four per 10,000 births, which makes this condition officially a rare disease. Based on 2008 birth rates in the EU-27, this would mean between 542 and 2168 children in EU-27 [1]. CDH is the denominator for posterior lateral (Bochdalek 95%) and anterior (Morgagni defects). Eighty-six percent of Bochdalek defects are left-sided, 13% right-sided, and up to 2% bilateral. CDH is further classified as either isolated, syndromic or associated with other anomalies. In its isolated form, CDH leads to two neonatal problems: (1) the anatomical yet surgically correctable diaphragmatic defect; and (2) the coinciding pulmonary hypoplasia. The latter is the result of disturbed lung development, which starts in the embryonic period. As pregnancy continues, viscera herniate into the chest, and compete for space with the developing lungs. CDH lungs have fewer airway branches, smaller cross-sectional area of pulmonary vessels, structural vascular remodelling, and vasoconstriction with altered vasoreactivity [2]. The degree of lung development is individually quite variable; whether this is related to the size of the defect, or primarily determined by an initial underlying problem or a combination of both, remains uncertain. The in-utero death rate is around 2%, usually without demonstrable direct cause. At birth, the immediate problems are respiratory insufficiency and persistent pulmonary hypertension (PHT). Once the newborn is stabilized, the defect is corrected, which may for large defects require the use of a patch (reviewed in [3]). When the condition is not isolated, the prognosis is usually poor, as the above problems are combined with those caused by the other associated anomalies. In isolated cases, the condition is lethal in up to 30%, despite prenatal referral to a high volume center offering standardized neonatal care [4], [5], [6]. Survivors may suffer from additional morbidities, mainly chronic lung disease and/or persistent PHT, gastroesophageal reflux and feeding problems, and thoracic deformations [7]. Most babies eventually lead a life very close to normal provided they are managed in a multidisciplinary follow-up program [8], [9].
In the western world, >60% of cases are diagnosed at the latest by the second trimester screening ultrasound. As for any suspected congenital birth defect, its diagnosis should prompt referral to a tertiary center for confirmation of, or differential diagnosis, further documentation of severity and exclusion of associated problems (Box 1). This will be followed by multidisciplinary counseling of parents by specialists with experience in managing the condition. Additional diagnostic steps include genetic testing, and where applicable advanced imaging, which today will include magnetic resonance. The overall goal is to define the individual prognosis, so that parents, based on factual information regarding their fetus, can choose further management, which includes expectant management with prenatal referral to a high volume center for carefully timed delivery, termination of pregnancy, or fetal intervention for selected patients.
Section snippets
Microarray analysis
In recent years, genetic testing for prenatal diagnosis has moved beyond conventional karyotyping. The Leuven Centre for Human Genetics moved early to introduce chromosomal microarray analysis for prenatal diagnosis in the presence of ultrasound anomalies [12], which by now is the first-tier diagnostic test for routine prenatal diagnosis in Belgium [13]. We demonstrated the added value of chromosomal microarrays for the investigation of apparently isolated CDH, both retrospectively using a
Prenatal imaging for assessment of severity
Next to ruling out additional anomalies, ultrasound and magnetic resonance imaging are used to assess severity. This topic is reviewed in depth by Benachi et al. [27]. In essence, two-dimensional ultrasound enables assessment of lung size and identification of position of the liver. Both parameters have been named to be predictive of outcome, though it remains unknown whether they act independently. Other less studied factors are position of the stomach, polyhydramnios, gestation at diagnosis
Fetal therapy
The ability to prenatally identify a future non-survivor prompts the search for an intervention that can avoid that outcome. As CDH is a developmental problem, the ideal therapeutic window of opportunity is the prenatal period. Historically this was first done by in-utero anatomical repair [57]. Today the only clinically applied intervention is fetal endoluminal tracheal occlusion (FETO; Fig. 3). TO for alleviation of pulmonary hypoplasia was to our knowledge first proposed by Jay Wilson and
Future perspectives in genetics and non-surgical strategies
The current clinical experience with fetal surgery yields less than desirable survival rates. Nor can the side-effects of FETO be ignored (up to 25% membrane rupture and preterm delivery rate) (Fig. 6). Due to its technical complexity and logistic demands, fetal surgery is neither universally applicable nor available. Therefore alternative, less invasive and/or more potent and/or easy methods for forced lung growth should be explored. Pharmacological or cell-based strategies are attractive
Acknowledgements
J.D.P. is a fundamental clinical researcher supported by the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO; 1.801207). E.G. and J.D. steer an Erasmus Joint Doctoral program of the Universities of Barcelona, Leuven and Lund, which is sponsored by the European Commission (2013-0040). The TOTAL trial was initially set up within the framework of the “Eurostec” FP-6 program (EuroSTEC, LSHC-CT-2006-037409) on perinatal tissue engineering for congenital birth defects, sponsored by the European
References (107)
- et al.
Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late, and chronic pulmonary hypertension
Semin Perinatol
(2005) - et al.
Effect of hospital case volume on outcome in congenital diaphragmatic hernia: the experience of the Canadian Pediatric Surgery Network
J Pediatr Surg
(2009) - et al.
Long term respiratory outcomes of congenital diaphragmatic hernia, esophageal atresia, and cardiovascular anomalies
Semin Fetal Neonat Med
(2012) - et al.
Antenatal diagnosis of congenital diaphragmatic hernia
Semin Perinatol
(2005) - et al.
A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors
Genet Med
(2014) - et al.
Implementation of genomic arrays in prenatal diagnosis: the Belgian approach to meet the challenges
Eur J Med Genet
(2014) - et al.
Xq12q13.1 microduplication encompassing the EFNB1 gene in a boy with congenital diaphragmatic hernia
Eur J Med Genet
(2011) - et al.
Exome sequencing identifies ZFPM2 as a cause of familial isolated congenital diaphragmatic hernia and possibly cardiovascular malformations
Eur J Med Genet
(2014) - et al.
Exome sequencing identifies a recessive PIGN splice site mutation as a cause of syndromic congenital diaphragmatic hernia
Eur J Med Genet
(2014) - et al.
Congenital diaphragmatic hernia: lung-to-head ratio and lung volume for prediction of outcome
Am J Obstet Gynecol
(2011)
Antenatal prediction of lung volume and in-utero treatment by fetal endoscopic tracheal occlusion in severe isolated congenital diaphragmatic hernia
Semin Fetal Neonatal Med
Right congenital diaphragmatic hernia: prenatal assessment and outcome
J Pediatr Surg
The current profile and outcome of congenital diaphragmatic hernia: a nationwide survey in Japan
J Pediatr Surg
Congenital diaphragmatic hernia: a meta-analysis of mortality factors
J Pediatr Surg
Right-sided congenital diaphragmatic hernia: high utilization of extracorporeal membrane oxygenation and high survival
J Pediatr Surg
The plug–unplug sequence: an important step to achieve type II pneumocyte maturation in the fetal lamb model
J Pediatr Surg
Tracheoscopic endoluminal plugging using an inflatable device in the fetal lamb model
Eur J Obstet Gynecol Reprod Biol
Endoscopic in utero tracheal plugging in the fetal lamb to treat congenital diaphragmatic hernia
J Am Assoc Gynecol Laparosc
Technical aspects of fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia
J Pediatr Surg
Routine isolation and expansion late mid trimester amniotic fluid derived mesenchymal stem cells in a cohort of fetuses with congenital diaphragmatic hernia
Eur J Obstet Gynecol Reprod Biol
Neonatal tracheal changes following in utero fetoscopic balloon tracheal occlusion in severe congenital diaphragmatic hernia
J Pediatr Surg
Tracheomegaly in infants with severe congenital diaphragmatic hernia treated with fetal endoluminal tracheal occlusion
J Pediatr
Prenatal treatment with retinoic acid accelerates type 1 alveolar cell proliferation of the hypoplastic lung in the nitrofen model of congenital diaphragmatic hernia
J Pediatr Surg
Congenital diaphragmatic hernia
Eur Respir J
A review of patch options in the repair of congenital diaphragm defects
Pediatr Surg Int
Actual outcome in infants with congenital diaphragmatic hernia: the role of a standardized postnatal treatment protocol
Fetal Diagn Ther
Effect of hospital volume on the mortality of congenital diaphragmatic hernia in Japan
Pediatr Int
Postdischarge follow-up of infants with congenital diaphragmatic hernia
Pediatrics
Can we improve outcome of congenital diaphragmatic hernia?
Pediatr Surg Int
Population-based study of congenital diaphragmatic hernia: risk factors and survival in Metropolitan Atlanta, 1968–1999
Birth Defects Res A Clin Mol Teratol
Targeted array comparative genomic hybridisation (array CGH) identifies genomic imbalances associated with isolated congenital diaphragmatic hernia (CDH)
Prenat Diagn
Identification of dosage-sensitive genes in fetuses referred with severe isolated congenital diaphragmatic hernia
Prenat Diagn
Associated malformations in cases with congenital diaphragmatic hernia
Genet Couns
Genomic alterations that contribute to the development of isolated and non-isolated congenital diaphragmatic hernia
J Med Genet
De novo copy number variants are associated with congenital diaphragmatic hernia
J Med Genet
Fog2 is required for normal diaphragm and lung development in mice and humans
PLoS Genet
Variants in GATA4 are a rare cause of familial and sporadic congenital diaphragmatic hernia
Hum Genet
Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic hernia
Clin Genet
Expanding the phenotypic spectrum of PORCN variants in two males with syndromic microphthalmia
Eur J Hum Genet
Whole exome sequencing identifies de novo mutations in GATA6 associated with congenital diaphragmatic hernia
J Med Genet
Advances in prenatal diagnosis of congenital diaphragmatic hernia
Semin Fetal Neonat Med
Fetal lung growth in congenital diaphragmatic hernia
Fetal Diagn Ther
Sonographic predictors of survival in fetal diaphragmatic hernia
J Pediatr Surg
Assessment of lung area in fetuses with congenital diaphragmatic hernia
Ultrasound Obstet Gynecol
Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia
Ultrasound Obstet Gynecol
Prenatal prediction of neonatal morbidity in survivors with congenital diaphragmatic hernia: a multicenter study
Ultrasound Obstet Gynecol
Prenatal prediction of survival in isolated diaphragmatic hernia using observed to expected total fetal lung volume determined by magnetic resonance imaging based on either gestational age or fetal body volume
Ultrasound Obstet Gynecol
Fetal body volume: use at MR imaging to quantify relative lung volume in fetuses suspected of having pulmonary hypoplasia
Radiology
Fetal body volume at MR imaging to quantify total fetal lung volume: normal ranges
Radiology
A comparison of matching fetuses by body volume or gestational age for calculation of the observed to expected total fetal lung volume (o/e TFLV) in fetuses with isolated congenital diaphragmatic hernia (CDH)
Ultrasound Obstet Gynecol
Cited by (149)
Treatment Facility Case Volume and Disparities in Outcomes of Congenital Diaphragmatic Hernia Cases
2024, Journal of Pediatric SurgeryTranspyloric Tube Placement Shortens Time to Full Feeding in Left Congenital Diaphragmatic Hernia
2023, Journal of Pediatric SurgeryA pneumonectomy model to study flow-induced pulmonary hypertension and compensatory lung growth
2023, Cell Reports MethodsRisk Stratification by Percent Liver Herniation in Congenital Diaphragmatic Hernia
2023, Journal of Surgical ResearchPrenatal management of congenital diaphragmatic hernia
2022, Seminars in Fetal and Neonatal MedicineComplications of Gynecologic Surgery: CO<inf>2</inf> Massive Pneumothorax after a Total Laparoscopic Hysterectomy
2022, Journal of Minimally Invasive Gynecology